RNA FY 2024 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+14.0% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$379M-3477.4% margin

Net Income

-$322M-2957.7% margin

EPS (Diluted)

$-2.89

Cash Flow

Operating Cash Flow

-$301M

Free Cash Flow

-$308M

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$139M

Stockholders' Equity

$1.4B

Cash & Equivalents

$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$10M	+14.0%
Gross Profit	$11M	$7M	+46.1%
Operating Income	-$379M	-$236M	-60.8%
Net Income	-$322M	-$212M	-51.9%